Who Paid My Doc
Richard Weiner
Podiatrist, Foot Surgery Dallas, TX Doctor of Podiatric Medicine
NPI 1578566238 CMS profile 252517
4523 W Lovers Ln, Dallas, TX 75209
General payments
$11,131
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Richard Weiner of Dallas, TX is reported in the CMS Open Payments database as having received $11,131 across 36 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 93rd percentile of Podiatrist, Foot Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $172 | 2 | |
| 2022 | General | $457 | 5 | |
| 2021 | General | $720 | 6 | |
| 2020 | General | $44 | 2 | |
| 2019 | General | $9,738 | 21 |
Beside peers
- Richard Weiner
- Podiatrist, Foot Surgery median
- Middle half of Podiatrist, Foot Surgery
- National median
In program year 2025, general payments to Richard Weiner were reported at $0. Among 732 Podiatrist, Foot Surgery profiles paid that year, the median was $180 and the middle half received between $70 and $569.
Show as a table
| Year | Richard Weiner | Podiatrist, Foot Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $9,738 | $167 | $67–$484 | $163 |
| 2020 | $44 | $114 | $40–$323 | $114 |
| 2021 | $720 | $171 | $57–$502 | $132 |
| 2022 | $457 | $196 | $66–$556 | $149 |
| 2023 | $172 | $187 | $78–$466 | $160 |
| 2024 | $0 | $190 | $78–$557 | $164 |
| 2025 | $0 | $180 | $70–$569 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 4 billing codesPaid by Medicare
$1,350
Medicare patients
18
Services billed
28
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Arthritis | 75% | |
| High blood pressure | 72% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
36 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Podiatrist, Foot Surgery in Texas
Marque Allen
Podiatrist, Foot Surgery · San Antonio, TX
James Jacobs
Podiatrist, Foot Surgery · Katy, TX
Lawrence Lavery
Podiatrist, Foot Surgery · San Antonio, TX
Robert Graser
Podiatrist, Foot Surgery · Boerne, TX
Richard Keh
Podiatrist, Foot Surgery · San Antonio, TX
Chad Clause
Podiatrist, Foot Surgery · Webster, TX
Related records
Podiatrist, Foot Surgery in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Podiatrist, Foot Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.